Literature DB >> 4979978

Development of drug resistance to rifampicin.

A Manten, L J Van Wijngaarden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4979978     DOI： 10.1159/000220615

Source DB:  PubMed          Journal:  Chemotherapy        ISSN： 0009-3157            Impact factor:   2.544


× No keyword cloud information.
  5 in total

Review 1.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus.

Authors:  D R Moorman; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

3.  Potential mechanisms of attenuation for rifampicin-passaged strains of Flavobacterium psychrophilum.

Authors:  Karol Gliniewicz; Mark Wildung; Lisa H Orfe; Gregory D Wiens; Kenneth D Cain; Kevin K Lahmers; Kevin R Snekvik; Douglas R Call
Journal:  BMC Microbiol       Date:  2015-09-16       Impact factor: 3.605

4.  rpoB mutations conferring rifampicin-resistance affect growth, stress response and motility in Vibrio vulnificus.

Authors:  Laura Cutugno; Jennifer Mc Cafferty; Jan Pané-Farré; Conor O'Byrne; Aoife Boyd
Journal:  Microbiology (Reading)       Date:  2020-12       Impact factor: 2.777

Review 5.  Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB).

Authors:  Caio H N Barros; Stephanie Fulaz; Danijela Stanisic; Ljubica Tasic
Journal:  Antibiotics (Basel)       Date:  2018-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.